Atul Kumar, Subijay Sinha. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultAngiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedBevacizumabFluorescein AngiographyHumansInjectionsMaleOptic Disk/blood supplyRetinal Neovascularization/drug therapyRetinal Neovascularization/etiologyRetinal Vasculitis/complicationsVascular Endothelial Growth Factor A/antagonists & inhibitorsVitreous Body
Substances: See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedVEGFA protein, humanVascular Endothelial Growth Factor ABevacizumab
Year: 2007 PMID: 17392871 DOI: 10.3129/can j ophthalmol.i07-026
Source DB: PubMed Journal: Can J Ophthalmol ISSN: 0008-4182 Impact factor: 1.882